New drug ARO-ANG3 tested for safety in high cholesterol patients
NCT ID NCT03747224
First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 21 times
Summary
This early-stage study tested a new drug called ARO-ANG3 in 93 healthy adults and patients with high cholesterol or high triglycerides. The main goal was to check safety and how the drug moves through the body. Researchers gave single or multiple doses to see if it could help control these conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTRIGLYCERIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site 1
Nedlands, 6009, Australia
-
Research Site 2
Camperdown, New South Wales, 2050, Australia
-
Research Site 3
Adelaide, South Australia, 5000, Australia
-
Research Site 4
Grafton, Auckland, 1010, New Zealand
-
Research Site 5
Papatoetoe, Aukland, 2025, New Zealand
-
Research Site 6
Christchurch, 8011, New Zealand
Conditions
Explore the condition pages connected to this study.